BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1464874)

  • 1. The epidemiology of gout and hyperuricemia in a rural population of Java.
    Darmawan J; Valkenburg HA; Muirden KD; Wigley RD
    J Rheumatol; 1992 Oct; 19(10):1595-9. PubMed ID: 1464874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai.
    Chen S; Du H; Wang Y; Xu L
    Chin Med J (Engl); 1998 Mar; 111(3):228-30. PubMed ID: 10374422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96).
    Chang HY; Pan WH; Yeh WT; Tsai KS
    J Rheumatol; 2001 Jul; 28(7):1640-6. PubMed ID: 11469473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-specific factors associated with fractional excretion of uric acid.
    Narang RK; Vincent Z; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2019 Nov; 21(1):234. PubMed ID: 31718705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.
    Miao Z; Li C; Chen Y; Zhao S; Wang Y; Wang Z; Chen X; Xu F; Wang F; Sun R; Hu J; Song W; Yan S; Wang CY
    J Rheumatol; 2008 Sep; 35(9):1859-64. PubMed ID: 18634142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic exposure, hyperuricemia, and gout in US adults.
    Kuo CC; Weaver V; Fadrowski JJ; Lin YS; Guallar E; Navas-Acien A
    Environ Int; 2015 Mar; 76():32-40. PubMed ID: 25499256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China: A preliminary study.
    Zhang Q; Gong H; Lin C; Liu Q; Baima Y; Wang Y; Lin J
    Medicine (Baltimore); 2020 Jan; 99(2):e18542. PubMed ID: 31914028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
    J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we be more aware of gender aspects in hyperuricemia? Analysis of the population-based German health interview and examination survey for adults (DEGS1).
    Engel B; Hoffmann F; Freitag MH; Jacobs H
    Maturitas; 2021 Nov; 153():33-40. PubMed ID: 34654526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
    Ito S; Torii T; Nakajima A; Iijima T; Murano H; Horiuchi H; Yamanaka H; Honda M
    BMC Pediatr; 2020 Oct; 20(1):481. PubMed ID: 33059648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Apr; 27(4):1045-50. PubMed ID: 10782835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS).
    Teramura S; Yamagishi K; Umesawa M; Hayama-Terada M; Muraki I; Maruyama K; Tanaka M; Kishida R; Kihara T; Takada M; Ohira T; Imano H; Shimizu Y; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H
    J Atheroscler Thromb; 2023 Oct; 30(10):1483-1491. PubMed ID: 36878531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of gout and hyperuricemia in New Caledonia.
    Bardin T; Magnat E; Clerson P; Richette P; Rouchon B
    Joint Bone Spine; 2022 Mar; 89(2):105286. PubMed ID: 34601114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Sex Disparities in Gout Prevalence Among US Adults.
    McCormick N; Lu N; Yokose C; Joshi AD; Sheehy S; Rosenberg L; Warner ET; Dalbeth N; Merriman TR; Saag KG; Zhang Y; Choi HK
    JAMA Netw Open; 2022 Aug; 5(8):e2226804. PubMed ID: 35969396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of uric acid and fructose.
    Rho YH; Zhu Y; Choi HK
    Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced glomerular function and prevalence of gout: NHANES 2009-10.
    Krishnan E
    PLoS One; 2012; 7(11):e50046. PubMed ID: 23209642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.
    Chuang SY; Lee SC; Hsieh YT; Pan WH
    Asia Pac J Clin Nutr; 2011; 20(2):301-8. PubMed ID: 21669599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uric acid excretion in hyperuricemia and gout].
    FRIEDRICH S; MUGLER A
    Strasb Med; 1956 Jul; 7(7):492-503. PubMed ID: 13360594
    [No Abstract]   [Full Text] [Related]  

  • 19. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.
    Chen-Xu M; Yokose C; Rai SK; Pillinger MH; Choi HK
    Arthritis Rheumatol; 2019 Jun; 71(6):991-999. PubMed ID: 30618180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.
    Roman YM
    Hawaii J Med Public Health; 2019 Feb; 78(2):71-76. PubMed ID: 30766768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.